Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples